The Cymbalta Pregnancy Registry
NCT01074151 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144
Last updated 2022-07-18
Summary
The Cymbalta Pregnancy Registry is a U.S. based Registry designed to monitor women who are exposed to Cymbalta (duloxetine) during pregnancy. This is an observational, exposure-registration and follow-up registry.
Conditions
- Pregnancy
Interventions
- DRUG
-
duloxetine
any exposure to duloxetine that occurred during pregnancy
Sponsors & Collaborators
- collaborator OTHER
- lead INDUSTRY
Principal Investigators
-
INC Research, LLC · Syneos Health
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2021-07-26
- Completion
- 2021-07-26
Countries
- United States
Study Locations
More Related Trials
-
Early PrEgnancy Complications Testing
NCT04079361 ·Status: RECRUITING ·Phase: NA
-
Evolocumab Pregnancy Exposure Registry
NCT02957604 ·Status: TERMINATED
-
Exploring Central Sensitization in Pregnant Women
NCT05507853 ·Status: RECRUITING
-
Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum: Evaluation of Clinical Practices in Five Maternity Hospitals in Île-de-France
NCT06841029 ·Status: COMPLETED
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
NCT06258902 ·Status: RECRUITING
-
Varenicline Pregnancy Cohort Study
NCT01290445 ·Status: COMPLETED
-
Bempedoic Acid Pregnancy Surveillance Program
NCT05103254 ·Status: RECRUITING
-
Evaluation of Drug's Risk in Pregnant Women
NCT02818842 ·Status: RECRUITING
-
Chronic Hypertension and Pregnancy (CHAP) Project
NCT02299414 ·Status: COMPLETED ·Phase: PHASE4
-
Electronic Cigarette Use During Pregnancy
NCT03480373 ·Status: COMPLETED
-
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
NCT06498128 ·Status: RECRUITING
-
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
NCT06113237 ·Status: RECRUITING
-
Patients' Choice of Health Care Provider for Monitoring Their Pregnancy
NCT05774353 ·Status: COMPLETED ·Phase: NA
-
Retrospective Analysis of Hospital Medical Records on Medication and Supplement Use in Pregnant Women
NCT02842216 ·Status: COMPLETED
-
Molecular Basis of Altered Drug Metabolism During Pregnancy
NCT03654378 ·Status: WITHDRAWN
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Assessment of Women's Insight and Understanding of Down's Syndrome Screening by Non-invasive Prenatal Testing (NIPT) During Their First Ultrasound
NCT03549286 ·Status: UNKNOWN
-
Effect of Antenatal SSRI Exposure on the QT Interval of Neonates
NCT02492347 ·Status: COMPLETED ·Phase: NA
-
Pregnancy Outcomes in Congenital Myasthenie Syndrome
NCT01474980 ·Status: COMPLETED
-
Better Understanding the Metamorphosis of Pregnancy (BUMP)
NCT04714905 ·Status: COMPLETED
-
Betaseron Pregnancy Registry
NCT00317564 ·Status: COMPLETED
-
Prenatal Mindfulness & Hypertension Study
NCT03679117 ·Status: COMPLETED ·Phase: NA
-
Immunological and Cardiovascular Phenotyping of Oocyte-donation Pregnancies
NCT04731012 ·Status: RECRUITING
-
The 3D Cohort Study (Design, Develop, Discover)
NCT03113331 ·Status: ACTIVE_NOT_RECRUITING